2011
DOI: 10.4103/0253-7613.81519
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo antioxidant activities of the aqueous extract of Celosia argentea leaves

Abstract: Objective:The aqueous extract of Celosia argentea var. cristata L. leaves at 100, 200, and 400 mg/kg body weight (b.w.) was investigated against cadmium (Cd)-induced oxidative stress in Wistar rats. The in vitro antioxidant of the extract was evaluated using ammonium thiocyanate, reducing power, and membrane stabilizing models.Materials and Methods:For the in vivo study, 30 male rats (Rattus norvegicus) weighing 138.02 ± 7.02 g were completely randomized into 6 groups (A–F) of 5 animals each. Animals in groups… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(23 citation statements)
references
References 19 publications
2
16
0
Order By: Relevance
“…30 min before the experiments. The doses of MECC were selected from trial and previously reported effective doses of C. cristata [ 29 ]. To evaluate the involvement of opioid-mediated antinociceptive activity, naloxone was administered (i.p.)…”
Section: Methodsmentioning
confidence: 99%
“…30 min before the experiments. The doses of MECC were selected from trial and previously reported effective doses of C. cristata [ 29 ]. To evaluate the involvement of opioid-mediated antinociceptive activity, naloxone was administered (i.p.)…”
Section: Methodsmentioning
confidence: 99%
“…and L-ascorbic acid (100 mg/kg b.w.). The dose of chlorambucil administered to the animals was based on the recommended dose in the treatment of Hodgkin's lymphoma (0.1-0.2 mg/kg/day) [ 33 ], while doses of ascorbic acid and kolaviron were selected based on the results obtained from previous studies in experimental animals [ 34 , 35 ]. Each of the drug doses was delivered orally in 1 mL solution, once daily using an oral cannula.…”
Section: Methodsmentioning
confidence: 99%
“…The assay was performed as described by Malomo et al [34] The assay mixture consisted of PBS, indomethacin (reference drug) or different concentrations of FA or its derivatives, and 2% erythrocyte suspension in isosaline. The control was prepared without the reference drug (or FA/derivatives) whereas the drug control and the FA control lacked erythrocyte suspension.…”
Section: Membrane Stabilizing Effectmentioning
confidence: 99%